Just in time for National Gum Care Month, a new study, published in the peer-reviewed journal Archives of Medical Science, demonstrates that a comprehensive approach to heart attack, stroke and diabetes prevention that includes oral wellness—our patented BaleDoneen Method—can quickly shrink the size of arterial plaque deposits by more than 50% in patients with cardiovascular disease (CVD), the leading killer of American men and women.
Together with scientists from Johns Hopkins Ciccarone Center for Prevention of Heart Disease, we studied 324 patients at the Heart Attack & Stroke Prevention Center in Spokane, Washington, all of whom received comprehensive cardiovascular risk reduction treatments that included lipid-lowering medications (statin, niacin, and/ezetimibe), lifestyle modification, and additional therapies for those with insulin resistance, type 2 diabetes, hypertension, metabolic syndrome and other CV risks.
During the first year of treatment, our personalized medical management of these patients lead to a 52.7% decrease in the size of plaque deposits in their neck arteries, compared to baseline, as measured by carotid intima media thickness (cIMT) ultrasound imaging. Not only did the plaque get smaller, but it also stabilized, helping these patients avoid heart attacks and strokes. (None of these events occurred during the study.)
After just one year of our individualized medical management, outcomes were as follows:
Further benefits were seen during the second year of treatment, including:
Optimal oral health is a key component of the BaleDoneen Method, which is based on a disease/inflammatory approach to vascular wellness. Given the multifactorial nature of CVD, and the well-established oral-systemic connection, a medical/dental team approach is essential to help patients achieve optimal cardiovascular wellness. We offer a 2-day CME/CE course for medical and dental providers that teaches the necessary measures to collaborate effectively on heart attack and stroke prevention.
The BaleDoneen Method offers more than an evidence-based approach to prevent, halt or treat CVD. It is also an educational platform that strives to unite all of these medical and dental providers in harnessing leading-edge science in the fight to eradicate the no. 1 threat to our patients: CVD—not just in National Gum Care Month, but throughout the year, in a collaboration that really is lifesaving!